These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

23 related articles for article (PubMed ID: 3295210)

  • 1. Specific Aspects of Eye Movement Reactions as Markers of Cognitive Control Disorders in Patients with Obsessive-Compulsive Disorder (Review).
    Khayrullina GM; Moiseeva VV; Martynova OV
    Sovrem Tekhnologii Med; 2022; 14(2):80-95. PubMed ID: 37065423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Saccadic eye movement applications for psychiatric disorders.
    Bittencourt J; Velasques B; Teixeira S; Basile LF; Salles JI; Nardi AE; Budde H; Cagy M; Piedade R; Ribeiro P
    Neuropsychiatr Dis Treat; 2013; 9():1393-409. PubMed ID: 24072973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological treatment effects on eye movement control.
    Reilly JL; Lencer R; Bishop JR; Keedy S; Sweeney JA
    Brain Cogn; 2008 Dec; 68(3):415-35. PubMed ID: 19028266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of pharmacologic catecholamine manipulation on smooth pursuit eye movements in normals.
    Malaspina D; Colemann EA; Quitkin M; Amador XF; Kaufmann CA; Gorman JM; Sackeim HA
    Schizophr Res; 1994 Sep; 13(2):151-9. PubMed ID: 7986772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Schizotypy and smooth pursuit eye movements as potential endophenotypes of obsessive-compulsive disorder.
    Bey K; Meyhöfer I; Lennertz L; Grützmann R; Heinzel S; Kaufmann C; Klawohn J; Riesel A; Ettinger U; Kathmann N; Wagner M
    Eur Arch Psychiatry Clin Neurosci; 2019 Mar; 269(2):235-243. PubMed ID: 29721727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of procyclidine on eye movements in schizophrenia.
    Ettinger U; Kumari V; Zachariah E; Galea A; Crawford TJ; Corr PJ; Taylor D; Das M; Sharma T
    Neuropsychopharmacology; 2003 Dec; 28(12):2199-208. PubMed ID: 12942142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. D-amphetamine in obsessive-compulsive disorder.
    Insel TR; Hamilton JA; Guttmacher LB; Murphy DL
    Psychopharmacology (Berl); 1983; 80(3):231-5. PubMed ID: 6412267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of lithium treatment on eye movements.
    Holzman PS; O'Brian C; Waternaux C
    Biol Psychiatry; 1991 May; 29(10):1001-15. PubMed ID: 2065136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eye-tracking, attention and amphetamine challenge.
    Siever LJ; Insel TR; Hamilton J; Nurnberger J; Alterman I; Murphy DL
    J Psychiatr Res; 1987; 21(2):129-35. PubMed ID: 3295210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eye tracking in normals: spem asymmetries and association with schizotypy.
    Kelley MP; Bakan P
    Int J Neurosci; 1999; 98(1-2):27-81. PubMed ID: 10395362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eye movement dysfunction as a biological marker of risk for schizophrenia.
    Lee KH; Williams LM
    Aust N Z J Psychiatry; 2000 Nov; 34 Suppl():S91-100. PubMed ID: 11129321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eye movement dysfunctions and psychosis.
    Holzman PS
    Int Rev Neurobiol; 1985; 27():179-205. PubMed ID: 2867978
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.